A randomized, placebo-controlled, double-blind phase 2 study of docetaxel compared to docetaxel plus zosuquidar (LY335979) in women with metastatic or locally recurrent breast cancer who have received one prior chemotherapy regimen
Paul Ruff(University of the Witwatersrand), Daniel Vorobiof(Morningside College), J. P. Jordaan(Addington Hospital), Georgia Demetriou(University of the Witwatersrand), S. D. Moodley(University of the Witwatersrand), Adam Nosworthy(University of the Witwatersrand), I. D. Werner(Groote Schuur Hospital), Johann Raats, Lesley Burgess(Tygerberg Hospital)
Cited by 83
Abstract
Related Papers
No related papers found
Powered by citation graph analysis